D-GPCR: A novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate

Biochemical and Biophysical Research Communications

Volumn 322, Issue 1, 2004, Pages 239-249

  Weigle, Bernd ^a   Fuessel, Susanne ^a   Ebner, Reinhard ^b   Temme, Achim ^a   Schmitz, Marc ^a   Schwind, Sandra ^a   Kiessling, Andrea ^a   Rieger, Michael A ^a   Meye, Axel ^a   Bachmann, Michael ^a   Wirth, Manfred P ^a   Rieber, E Peter ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Avalon Pharmaceuticals   (United States)

Author keywords

G protein coupled receptor; Prostate cancer; Real time PCR

Indexed keywords

ANTIBODY; COMPLEMENTARY DNA; G PROTEIN COUPLED RECEPTOR; RECOMBINANT PROTEIN;

ARTICLE; CANCER TISSUE; CELL STRAIN; CONTROLLED STUDY; EMBRYO; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN FAMILY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; UPREGULATION;

AGED; AMINO ACID SEQUENCE; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED; SEQUENCE ANALYSIS, PROTEIN; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

EID: 4143129858     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.07.106     Document Type: Article

References (37)

1. M.A. Eisenberger, R. Simon, P.J. O'Dwyer, R.E. Wittes, and M.A. Friedman A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma J. Clin. Oncol. 3 1985 827 841
2. J. Rosenberg, and E.J. Small Prostate cancer update Curr. Opin. Oncol. 15 2003 217 221
3. M. Harada, M. Noguchi, and K. Itoh Target molecules in specific immunotherapy against prostate cancer Int. J. Clin. Oncol. 8 2003 193 199
4. L. Bubendorf, M. Kolmer, J. Kononen, P. Koivisto, S. Mousses, Y. Chen, E. Mahlamaki, P. Schraml, H. Moch, N. Willi, A.G. Elkahloun, T.G. Pretlow, T.C. Gasser, M.J. Mihatsch, G. Sauter, and O.P. Kallioniemi Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays J. Natl. Cancer Inst. 91 1999 1758 1764
5. S.M. Dhanasekaran, T.R. Barrette, D. Ghosh, R. Shah, S. Varambally, K. Kurachi, K.J. Pienta, M.A. Rubin, and A.M. Chinnaiyan Delineation of prognostic biomarkers in prostate cancer Nature 412 2001 822 826
6. J.H. Bull, G. Ellison, A. Patel, G. Muir, M. Walker, M. Underwood, F. Khan, and L. Paskins Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray Br. J. Cancer 84 2001 1512 1519
7. J. Luo, D.J. Duggan, Y. Chen, J. Sauvageot, C.M. Ewing, M.L. Bittner, J.M. Trent, and W.B. Isaacs Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling Cancer Res. 61 2001 4683 4688
8. J.B. Welsh, L.M. Sapinoso, A.I. Su, S.G. Kern, J. Wang-Rodriguez, C.A. Moskaluk, H.F. Frierson, and G.M. Hampton Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer Cancer Res. 61 2001 5974 5978
9. D. Singh, P.G. Febbo, K. Ross, D.G. Jackson, J. Manola, C. Ladd, P. Tamayo, A.A. Renshaw, A.V. D'Amico, J.P. Richie, E.S. Lander, M. Loda, P.W. Kantoff, T.R. Golub, and W.R. Sellers Gene expression correlates of clinical prostate cancer behavior Cancer Cell 1 2002 203 209
10. J.B. Welsh, L.M. Sapinoso, S.G. Kern, D.A. Brown, T. Liu, A.R. Bauskin, R.L. Ward, N.J. Hawkins, D.I. Quinn, P.J. Russell, R.L. Sutherland, S.N. Breit, C.A. Moskaluk, H.F. Frierson Jr., and G.M. Hampton Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum Proc. Natl. Acad. Sci. USA 100 2003 3410 3415
11. S.M. Henshall, D.E. Afar, K.K. Rasiah, L.G. Horvath, K. Gish, I. Caras, V. Ramakrishnan, M. Wong, U. Jeffry, J.G. Kench, D.I. Quinn, J.J. Turner, W. Delprado, C.S. Lee, D. Golovsky, P.C. Brenner, G.F. O'Neill, R. Kooner, P.D. Stricker, J.J. Grygiel, D.H. Mack, and R.L. Sutherland Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer Oncogene 22 2003 6005 6012
12. M.C. Wang, L.A. Valenzuela, G.P. Murphy, and T.M. Chu Purification of a human prostate specific antigen Invest. Urol. 17 1979 159 163
13. P. Vihko, P. Virkkunen, P. Henttu, K. Roiko, T. Solin, and M.L. Huhtala Molecular cloning and sequence analysis of cDNA encoding human prostatic acid phosphatase FEBS Lett. 236 1988 275 281
14. R.S. Israeli, C.T. Powell, W.R. Fair, and W.D.W. Heston Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen Cancer Res. 53 1993 227 230
15. L.L. Xu, B.G. Stackhouse, K. Florence, W. Zhang, N. Shanmugam, I.A. Sesterhenn, Z. Zou, V. Srikantan, M. Augustus, V. Roschke, K. Carter, D.G. McLeod, J.W. Moul, D. Soppett, and S. Srivastava PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer Cancer Res. 60 2000 6568 6572
16. C. Xia, W. Ma, F. Wang, S. Hua, and M. Liu Identification of a prostate-specific G-protein coupled receptor in prostate cancer Oncogene 20 2001 5903 5907
17. S.W. Edwards, C.M. Tan, and L.E. Limbird Localization of G-protein-coupled receptors in health and disease Trends Pharmacol. Sci. 21 2000 304 308
18. P. Mombaerts The human repertoire of odorant receptor genes and pseudogenes Annu. Rev. Genomics Hum. Genet. 2 2001 493 510
19. G.V. Raj, L. Barki-Harrington, P.F. Kue, and Y. Daaka Guanosine phosphate binding protein coupled receptors in prostate cancer: a review J. Urol. 167 2002 1458 1463
20. J.S. Taub, R. Guo, L.M. Leeb-Lundberg, J.F. Madden, and Y. Daaka Bradykinin receptor subtype 1 expression and function in prostate cancer Cancer Res. 63 2003 2037 2041
21. J.B. Nelson, S.P. Hedican, D.J. George, A.H. Reddi, S. Piantadosi, M.A. Eisenberger, and J.W. Simons Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate Nat. Med. 1 1995 944 949
22. A.L. Bookout, A.E. Finney, R. Guo, K. Peppel, W.J. Koch, and Y. Daaka Targeting Gbetagamma signaling to inhibit prostate tumor formation and growth J. Biol. Chem. 278 2003 37569 37573
23. G.L. Shen-Ong, Y. Feng, and D.A. Troyer Expression profiling identifies a novel alpha-methylacyl-CoA racemase exon with fumarate hydratase homology Cancer Res. 63 2003 3296 3301
24. L.H. Sobin, and C. Wittekind TNM classification of malignant tumors fifth ed. 1997 Wiley-Liss New York
25. S.F. Altschul, T.L. Madden, A.A. Schaffer, W. Zhang, W. Miller, and D.J. Lipman Gapped BLAST and PSI-BLAST: a new generation of protein database search programs Nucleic Acids Res. 25 1997 3389 3402
26. A. Temme, A. Buchmann, H.D. Gabriel, E. Nelles, M. Schwarz, and K. Willecke High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin 32 Curr. Biol. 7 1997 713 716
27. B. Weigle, A. Kiessling, R. Ebner, S. Fuessel, A. Temme, A. Meye, M. Schmitz, M.A. Rieger, D. Ockert, M.P. Wirth, and E.P. Rieber D-PCa-2: a novel transcript highly overexpressed in human prostate prostate cancer Int. J. Cancer 109 2004 882 892
28. A. Kiessling, S. Stevanovic, S. Fussel, B. Weigle, M.A. Rieger, A. Temme, E.P. Rieber, and M. Schmitz Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein Br. J. Cancer 90 2004 1034 1040
29. O. Kranenburg, and W.H. Moolenaar Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists Oncogene 20 2001 1540 1546
30. I.P. Whitehead, I.E. Zohn, and J.D. Channing Rho GTPase-dependent transformation by G protein-coupled receptors Oncogene 20 2001 1547 1555
31. S. Fukuhara, H. Chikumi, and J.S. Gutkind RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho? Oncogene 20 2001 1661 1668
32. M.J. Marinissen, and J.S. Gutkind G-protein-coupled receptors and signaling networks: emerging paradigms Trends Pharmacol. Sci. 22 2001 368 376
33. M.A. Carducci, R.J. Padley, J. Breul, N.J. Vogelzang, B.A. Zonnenberg, D.D. Daliani, C.C. Schulman, A.A. Nabulsi, R.A. Humerickhouse, M.A. Weinberg, J.L. Schmitt, and J.B. Nelson Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial J. Clin. Oncol. 21 2003 679 689
34. K. Regnauld, Q.D. Nguyen, L. Vakaet, E. Bruyneel, J.M. Launay, T. Endo, M. Mareel, C. Gespach, and S. Emami G-protein alpha(olf) subunit promotes cellular invasion, survival, and neuroendocrine differentiation in digestive and urogenital epithelial cells Oncogene 21 2002 4020 4031
35. L. Fong, and E.J. Small Immunotherapy for prostate cancer Semin. Oncol. 30 2003 649 658
36. J. Banchereau, A.K. Palucka, M. Dhodapkar, S. Burkeholder, N. Taquet, A. Rolland, S. Taquet, S. Coquery, K.M. Wittkowski, N. Bhardwaj, L. Pineiro, R. Steinman, and J. Fay Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine Cancer Res. 61 2001 6451 6458
37. J.D. Thompson, D.G. Higgins, and T.J. Gibson CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucleic Acids Res. 22 1994 4673 4680